OSE Immunotherapeutics OSE
PAR: OSE | ISIN: FR0012127173 12/06/2025
5,150 EUR (-2,65%)
(-2,65%)
12/06/2025
Profiel OSE Immunotherapeutics
CEO: Alexis Peyroles
CEO: Alexis Peyroles